However, given prior researches indicating that letrozole reduces estradiol levels and expedites luteolysis, substituting letrozole for GnRH antagonist in OHSS prevention not only lowers treatment costs but also eliminates the need for frequent injections, making it a more patient friendly option. Here, GNRH1 is linked to ovarian hyperstimulation syndrome.